The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...

In this final part of a recent interview with Jonathan Strober, MD, UCSF Benioff Children's Hospital and phase 2/3 ...

Zoryve (roflumilast) topical foam, 0.3% Phosphodiesterase type 4 inhibitor Treatment of plaque psoriasis of the scalp and body in adult and pediatric patients aged 12 years and older. Zoryve Foam 0.3% ...